U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
4.12+0.18 (+4.57%)
At close: 4:00PM EDT
People also watch
GNCACNATEVOKDRNAAKBA
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue4,4022,431-
Cost of Revenue---
Gross Profit4,4022,431-
Operating Expenses
Research Development26,45219,86116,435
Selling General and Administrative9,91310,3528,469
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-31,963-27,782-24,904
Income from Continuing Operations
Total Other Income/Expenses Net13810-430
Earnings Before Interest and Taxes-31,825-27,772-25,334
Interest Expense1,6372,220549
Income Before Tax-33,462-29,992-25,883
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-33,462-29,992-26,315
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-33,462-29,992-25,883
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-33,462-29,992-25,883